Mode
Text Size
Log in / Sign up

Higher plasma potassium levels associate with increased 30-day mortality in ED patients.

Higher plasma potassium levels associate with increased 30-day mortality in ED patients.
Photo by Cht Gsml / Unsplash
Key Takeaway
Note that higher plasma potassium levels associate with increased 30-day mortality in this cohort.

This retrospective cohort study evaluated 248,453 persons attending Emergency Departments in the Capital Region of Denmark between 2017 and 2021. The population included individuals with a plasma potassium level of at least 3.5 mM measured within 4 hours after arrival. The primary outcome was 30-day mortality, with the comparator being a plasma potassium level of 3.5 to 4.4 mM.

The analysis revealed a graded increase in 30-day mortality associated with higher plasma potassium levels. For patients with potassium levels of 4.5 to 4.9 mM, the absolute mortality rate was 6.9%. The adjusted hazard ratio was 1.4 (95% CI: 1.3–1.5). In the group with levels of 5.0 to 5.9 mM, the absolute mortality rate rose to 17.1%, corresponding to an adjusted hazard ratio of 2.10 (95% CI: 1.9–2.3). Patients with potassium levels of 6.0 mM or higher exhibited an absolute mortality rate of 26.9%, with an adjusted hazard ratio of 2.4 (95% CI: 2.0–2.8).

Safety and tolerability data were not reported in the provided text. Key limitations include the risk of residual confounding, missing data, and a lack of access to information regarding in-hospital treatment. The study examines the association between plasma potassium levels and 30-day mortality rather than establishing causality. These findings should be interpreted with caution regarding clinical management decisions.

Study Details

Study typeCohort
Sample sizen = 248,453
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Background: Potassium is involved in multiple physiological processes in the body, and hyperkalemia is a common, potentially life-threatening condition. Objective: The aim of our study was to examine the association between plasma potassium levels, and 30-day mortality in patients presenting to an emergency department with normo- or hyperkalemia. Design: Retrospective Cohort study. Setting: Emergency Departments in the Capital region of Denmark Participants: Persons attending Emergency Departments in the Capital Region of Denmark from 2017--2021 with a plasma potassium level of at least 3.5 mM measured within 4 hours after arrival. Measurements: The study was based on data from Danish National Registries and electronic patient records. We performed Kaplan-Meier survival analyses and unadjusted and adjusted cox regression analyses utilizing plasma [K+] 3.5--4.4 mM as the reference group for 30-day mortality hazard ratios (HRs). Results: A total of 248,453 patients were included with a median age of 60 years (Q1;Q3 42;75), and 6,959 (2.8%) died within 30 days. Mortality was 2.2% for potassium level 3.5--4.4 mM, 6.9% for 4.5--4.9 mM, 17.1% for 5.0--5.9 mM, and 26.9% for [≥] 6.0 mM. Unadjusted 30-day HRs were 3.2 (95%CI: 3.0--3.4) for [K+] 4.5--4.9 mM, 8.6 (95%CI: 7.9--9.3) for [K+] 5.0--5.9 mM, and 14.7 (95%CI: 12.5--17.0) for [K+] [≥]6.0 mM. Adjusted HRs were 1.4 (1.3--1.5), 2.10 (1.9--2.3), and 2.4 (2.0--2.8), respectively. Limitations: Risk of residual confounding. Missing data. No access to data regarding in-hospital treatment. Conclusion: Plasma potassium levels above 4.4 mM were associated with increased 30-day mortality among patients presenting to emergency departments. Primary funding source: Department of Emergency Medicine, Copenhagen University hospital, Bispebjerg and Frederiksberg Hospital.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.